These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17254776)

  • 1. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.
    Byrne B; Welsh J
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):703-7. PubMed ID: 17254776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
    Kemmis CM; Welsh J
    J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
    Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
    Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
    Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.
    Johnson AL; Zinser GM; Waltz SE
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E674-85. PubMed ID: 25139050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice.
    Zinser GM; Welsh J
    Mol Endocrinol; 2004 Sep; 18(9):2208-23. PubMed ID: 15178742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
    Wietzke JA; Ward EC; Schneider J; Welsh J
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
    Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
    Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium signaling in cancer and vitamin D.
    Sergeev IN
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):145-51. PubMed ID: 16081284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.
    Cui X; Pertile R; Liu P; Eyles DW
    Neuroscience; 2015 Sep; 304():90-100. PubMed ID: 26210580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-3 receptor as a target for breast cancer prevention.
    Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
    J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D in thyroid tumorigenesis and development.
    Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
    Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.